Related Experiment Videos
Complement-mediated solubilization of immune complexes in systemic lupus erythematosus
Clinical and Experimental Immunology
|April 1, 1982
Summary
Complex releasing activity (CRA) is significantly lower in active systemic lupus erythematosus (SLE) patients. CRA levels correlate with complement levels and may help monitor SLE disease activity.
Area of Science:
- Immunology
- Rheumatology
Background:
- Immune complexes (ICs) contribute to systemic lupus erythematosus (SLE) pathogenesis.
- Complement-mediated solubilization of ICs, termed complex releasing activity (CRA), is a crucial clearance mechanism.
Purpose of the Study:
- To investigate the diagnostic and prognostic utility of CRA in SLE patients.
- To determine the correlation between CRA and disease activity markers in SLE.
Main Methods:
- Quantification of CRA in sera from 63 SLE patients and controls.
- Correlation analysis of CRA with complement component levels (CH50, C4, C3) and circulating immune complexes (CICs).
Main Results:
- CRA was significantly lower in active SLE (35%) compared to inactive SLE (64.1%).
- Active SLE sera (20/23) showed CRA <50% of controls, while inactive SLE sera (29/40) exceeded 50%.
- CRA positively correlated with complement levels and negatively with CICs.
Conclusions:
- CRA is a potential biomarker for monitoring SLE disease activity.
- CRA reflects the functional status of both classical and alternative complement pathways in SLE.